Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency

Juan Li, Wei-Te Lei, Peng Zhang, Franck Rapaport, Yoann Seeleuthner, Bingnan Lyu, Takaki Asano, Jérémie Rosain, Boualem Hammadi, Yu Zhang, Simon J Pelham, András N Spaan, Mélanie Migaud, David Hum, Benedetta Bigio, Maya Chrabieh, Vivien Béziat, Jacinta Bustamante, Shen-Ying Zhang, Emmanuelle JouanguyStephanie Boisson-Dupuis, Jamila El Baghdadi, Vishukumar Aimanianda, Katharina Thoma, Manfred Fliegauf, Bodo Grimbacher, Anne-Sophie Korganow, Carol Saunders, V Koneti Rao, Gulbu Uzel, Alexandra F Freeman, Steven M Holland, Helen C Su, Charlotte Cunningham-Rundles, Claire Fieschi, Laurent Abel, Anne Puel, Aurélie Cobat, Jean-Laurent Casanova, Qian Zhang*, Bertrand Boisson*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Autosomal dominant (AD) NFKB1 deficiency is thought to be the most common genetic etiology of common variable immunodeficiency (CVID). However, the causal link between NFKB1 variants and CVID has not been demonstrated experimentally and genetically, as there has been insufficient biochemical characterization and enrichment analysis. We show that the cotransfection of NFKB1-deficient HEK293T cells (lacking both p105 and its cleaved form p50) with a κB reporter, NFKB1/p105, and a homodimerization-defective RELA/p65 mutant results in p50:p65 heterodimer–dependent and p65:p65 homodimer–independent transcriptional activation. We found that 59 of the 90 variants in patients with CVID or related conditions were loss of function or hypomorphic. By contrast, 258 of 260 variants in the general population or patients with unrelated conditions were neutral. None of the deleterious variants displayed negative dominance. The enrichment in deleterious NFKB1 variants of patients with CVID was selective and highly significant (P = 2.78 × 10−15). NFKB1 variants disrupting NFKB1/p50 transcriptional activity thus underlie AD CVID by haploinsufficiency, whereas neutral variants in this assay should not be considered causal.

Original languageEnglish
Article numbere20210566
JournalJournal of Experimental Medicine
Volume218
Issue number11
DOIs
Publication statusPublished - 1 Nov 2021
Externally publishedYes

Keywords

  • Animals
  • COS Cells
  • Cell Line
  • Chlorocebus aethiops
  • Common Variable Immunodeficiency/genetics
  • HEK293 Cells
  • Haploinsufficiency/genetics
  • Humans
  • NF-kappa B p50 Subunit/genetics
  • NF-kappa B/genetics
  • Phenotype
  • Transcriptional Activation/genetics

Fingerprint

Dive into the research topics of 'Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency'. Together they form a unique fingerprint.

Cite this